Tolvaptan/warfarinIncreased prothrombin time-international normalised ratio following drug-drug pharmacodynamic interaction: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1908卷 / 1期

关键词：

D O I：

10.1007/s40278-022-16253-z

中图分类号：

学科分类号：

摘要：

引用

页码：525 / 525

共 50 条

[1] HeparinProlongation of prothrombin time-international normalised ratio: case report
Reactions Weekly, 2023, 1981 (1) : 194 - 194
[2] WarfarinProlongation of prothrombin time-international normalised ratio: case report
Reactions Weekly, 2020, 1815 (1) : 308 - 308
[3] Ampicillin/sulbactam/meropenem/warfarinProthrombin time-international normalised ratio prolongation and drug interaction: case report
Reactions Weekly, 2023, 1976 (1) : 31 - 31
[4] Crizotinib/warfarin interactionIncreased prothrombin time-international normalised ratio: case report
Reactions Weekly, 2018, 1694 (1) : 140 - 140
[5] Rifampicin/warfarin interactionDecreased prothrombin time-international normalised ratio: case report
Reactions Weekly, 2023, 1954 (1) : 389 - 389
[6] WarfarinIncreased international normalised ratio: case report
Reactions Weekly, 2021, 1861 (1) : 314 - 314
[7] Variations in prothrombin time-international normalized ratio caused by drug-drug interaction in patients receiving warfarin: A retrospective observational study
Shiraishi, Chihiro
Hirai, Toshinori
Fujita, Satoshi
Dohi, Kaoru
Iwamoto, Takuya
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2023, 61 (04) : 139 - 147
[8] Crizotinib/warfarin interactionSupratherapeutic prothrombin time-international normalised ratio and intramuscular haematoma: case report
Reactions Weekly, 2019, 1775 (1) : 146 - 146
[9] Multiple drugsSevere serotonin syndrome following pharmacodynamic drug-drug interaction: case report
Reactions Weekly, 2024, 2030 (1) : 357 - 357
[10] Multiple drugsPneumonitis following drug-drug pharmacodynamic interaction and lack of efficacy: case report
Reactions Weekly, 2024, 2029 (1) : 470 - 470

← 1 2 3 4 5 →